Journal of International Oncology››2019,Vol. 46››Issue (8): 480-484.doi:10.3760/cma.j.issn.1673-422X.2019.08.007
Previous ArticlesNext Articles
Song Zhe1, Li Wei1, Jia Nan1, He Xiang2, Zhou Wenyong1
Received:
2019-04-10Revised:
2019-05-02Online:
2019-08-08Published:
2019-10-31Contact:
Song Zhe E-mail:13393275496@163.comSupported by:
Cangzhou Key Research and Development Program Guide Project (183302033)
Song Zhe, Li Wei, Jia Nan, He Xiang, Zhou Wenyong. Value of perfusion CT quantitative analysis for predicting tumor regression grade after chemoradiotherapy in patients with rectal cancer[J]. Journal of International Oncology, 2019, 46(8): 480-484.
[1] Dai J, Liao N, Shi J, et al. Study of prevalence and influencing factors of depression in tumor patients and the therapeutic effects of fluoxetine[J]. Eur Rev Med Pharmacol Sci, 2017, 21(21): 4966-4974. [2] Valentini V, Coco C, Picciocchi A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients[J]. Int J Radiat Oncol Biol Phys, 2002, 53(3): 664-674. DOI: 10.1016/s0360-3016(02)02764-5. [3] 钮东峰, 薛卫成. 直肠癌新辅助治疗后病理评估[J]. 中华胃肠外科杂志, 2018, 21(6): 632-636. DOI: 10.3760/cma.j.issn.1671-0274.2018.06.003. [4] Barbaro B, Vitale R, Leccisotti L, et al. Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy[J]. Radiographics, 2010, 30(3): 699-716. DOI: 10.1148/rg.303095085. [5] Kino A, Shaffer J, Maturen KE, et al. Perfusion CT measurements predict tumor response in rectal carcinoma[J]. Abdom Radiol (NY), 2017, 42(4): 1132-1140. DOI: 10.1007/s00261-016-0983-5. [6] Sun Y, Xiao Q, Hu F, et al. Diffusion kurtosis imaging in the characterisation of rectal cancer: utilizing the most repeatable region-of-interest strategy for diffusion parameters on a 3T scanner[J]. Eur Radiol, 2018, 28(12): 5211-5220. DOI: 10.1007/s00330-018-5495-y. [7] CurvoSemedo L, Portilha MA, Ruivo C, et al. Usefulness of perfusion CT to assess response to neoadjuvant combined chemoradiotherapy in patients with locally advanced rectal cancer[J]. Acad Radiol, 2012, 19(2): 203-213. DOI: 10.1016/j.acra.2011.10.019. [8] 周志鹏, 汤日杰, 李建生, 等. 直肠癌多层螺旋CT灌注参数与临床病理特征的相关性研究[J]. 中国CT和MRI杂志, 2017, 15(11): 113-115, 124. DOI: 10.3969/j.issn.1672-5131.2017.11.034. [9] Losi L, Luppi G, Gavioli M, et al. Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy[J]. Int J Colorectal Dis, 2006, 21(7): 645-651. DOI: 10.1007/s00384-005-0061-x. [10] 余涛, 安琦, 曹祥龙, 等. 中低位局部进展期直肠癌新辅助放化疗后肿瘤消退分级的预测因素研究[J]. 中华实验外科杂志, 2018, 35(3): 536-538. DOI: 10.3760/cma.j.issn.1001-9030.2018.03.043. [11] Krajnovi′c M, Markovi′c B, Kneˇzevi′c-Uˇzaj S, et al. Locally advanced rectal cancers with simultaneous occurrence of KRAS mutation and high VEGF expression show invasive characteristics[J]. Pathol Res Pract, 2016, 212(7): 598-603. DOI: 10.1016/j.prp.2016.02.018. [12] Del Gobbo A, Ferrero S. Immunohistochemical markers as predictors of histopathologic response and prognosis in rectal cancer treated with preoperative adjuvant therapy: state of the art[J]. Gastroenterol Res Pract, 2017, 2017: 2808235. DOI: 10.1155/2017/2808235. [13] Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations[J]. Radiology, 2005, 234(3): 785-792. DOI: 10.1148/radiol.2343040286. [14] Watanabe J, Ota M, Kawaguchi D, et al. Incidence and risk factors for rectovaginal fistula after low anterior resection for rectal cancer[J]. Int J Colorectal Dis, 2015, 30(12): 1659-1666. DOI: 10.1007/s00384-015-2340-5. [15] Kan Z, Phongkitkarun S, Kobayashi S, et al. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model[J]. Radiology, 2005, 237(1): 151-158. DOI: 10.1148/radiol.2363041293. [16] Sun LL, Song Z, Li WZ, et al. Hypoxia facilitates epithelial-mesenchymal transition-mediated rectal cancer progress[J]. Genet Mol Res, 2016, 15(4). DOI: 10.4238/gmr15048936. [17] Iv M, Fischbein NJ, Zaharchuk G. Association of developmental venous anomalies with perfusion abnormalities on arterial spin labeling and bolus perfusion-weighted imaging[J]. J Neuroimaging, 2015, 25(2): 243-250. DOI: 10.1111/jon.12119. [18] Bellomi M, Petralia G, Sonzogni A, et al. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience[J]. Radiology, 2007, 244(2): 486-493. DOI: 10.1148/radiol.2442061189. |
[1] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[2] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[3] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[4] | Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118. |
[5] | Liu Debao, Sun Ziwen, Lu Shoutang, Xu Haidong.Expression and clinical significance of ASB6 in colorectal cancer tissues[J]. Journal of International Oncology, 2023, 50(8): 470-474. |
[6] | Chen Zhuo, Tao Jun, Chen Lin, Ke Jing.Value of detection of peripheral blood miR-194 combined with fecal miR-143 in the clinical screening of colorectal cancer[J]. Journal of International Oncology, 2023, 50(5): 268-273. |
[7] | Zeng Liwu, Du Yuqiang, Zhang Peng, Tao Kaixiong.Progress in imaging evaluation of lateral lymph node metastasis in rectal cancer[J]. Journal of International Oncology, 2023, 50(4): 248-251. |
[8] | Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun.Construction of postoperative prognosis model for patients with colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 157-163. |
[9] | Xu Liangfu, Li Yuanfei.Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 186-190. |
[10] | Liu Yujie, Zhao Zhiqiang, Wang Zicheng.Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer[J]. Journal of International Oncology, 2023, 50(12): 717-722. |
[11] | Chen Yu, Xu Hua, Liu Hai, Chen Shixin.Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging[J]. Journal of International Oncology, 2023, 50(11): 655-660. |
[12] | Tao Hong, Yin Hong, Luo Hong, Tao Jiayu.Potential strategies for targeting tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors for colorectal cancer[J]. Journal of International Oncology, 2023, 50(11): 683-687. |
[13] | Wang Xi, Wu Chuanqing.Research progress in reversing multidrug resistance in colorectal cancer[J]. Journal of International Oncology, 2023, 50(1): 42-46. |
[14] | Song Tongjun, Deng Rui, Fei Lei, Lei Jinhua, Cao Fengjun.Comparison of the efficacy and safety of percutaneous needle biopsy of pulmonary or pleural lesions guided by CT and ultrasound[J]. Journal of International Oncology, 2022, 49(9): 526-531. |
[15] | Gao Yizhao, Liu Yang, Liu Qiulong, Xing Jinliang.Application of circulating cell-free nucleic acid in clinical diagnosis and treatment of colorectal cancer[J]. Journal of International Oncology, 2022, 49(9): 555-559. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||